Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venetoclax Combined with Dexamethasone for Newly Diagnosed t(11;14) AL Amyloidosis
NCT05996406Phase 2Active, not recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Sep 2023
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of venetoclax in light-chain amyloidosis, sponsored by Peking Union Medical College Hospital. Started Sep 2023; status: active, not recruiting.
02
Drugs
venetoclax
03
Conditions
light-chain amyloidosis
Beyond the preview
Go deeper on NCT05996406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05996406.